The book covers the latest breakthroughs in nanotechnology applied to cancer research. It examines how biomarkers and ligands are transforming preclinical cancer research by enabling the development of precision nanomedicines, targeted therapeutic strategies, and innovative drug delivery systems. Overall, by bridging multiple disciplines and providing a comprehensive overview of current advances and emerging trends, it equips readers with the knowledge to accelerate translational cancer research and the development of novel anticancer therapeutics.

The chapters delve into key concepts such as the design and synthesis of ligand-functionalized nanoparticles, the role of biomarkers in cancer prognosis, and the integration of nanotechnology in personalized medicine. Expert contributors provide insights into the use of nanoparticles for imaging and drug delivery, highlighting the potential of nanotechnology to enhance therapeutic efficacy while minimizing side effects.

The book is targeted towards oncologists, cancer researchers, medical students, pharmaceutical scientists, and healthcare professionals involved in cancer research and drug development. It serves as a valuable reference for research, fosters interdisciplinary collaboration, and provides an important resource for students and early-career researchers working in cancer nanotechnology and translational oncology.

Dr. Gautam Sethi is an Associate Professor in the department of pharmacology, at Yong Loo Lin School of Medicine, National University of Singapore. His research interests have been to elucidate the mechanism (s) of activation of oncogenic transcription factors by carcinogens and to identify novel inhibitors of these proteins for prevention and treatment of cancer. Dr. Sethi has several publications in peer-reviewed journals and serves as an editorial board member for numerous international journals. He has also been ranked among the world's most highly cited scientists according to the list of Highly Cited Researchers™ released by Clarivate and featured in Stanford University’s World’s Top 2% Scientists list.

Arun Kumar Singh has completed an M. Pharm (Pharmaceutics) from Galgotias University, Greater Noida, India. Mr. Singh is an assistant professor at the department of pharmacy, Vivekananda Global University Jaipur. His areas of interest are nano-formulation, blockchain, IoT, machine learning, cancer, artificial intelligence, big data, and neuroscience. He has authored several books, and review papers, and published 5 chapters in the field of big data.